| 1E9H | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | INR, TPO BindingDB | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1H1Q, 1H24, 1PXN | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate., Davies TG, Tunnah P, Meijer L, Marko D, Eisenbrand G, Endicott JA, Noble ME, Structure (Camb) 2001 May 9;9(5):389-97. PMID:11377199 | ||||||||||||||
| Data retrieval |
![]() |
| View 1E9H in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |